abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) announced a quarterly dividend on Tuesday, November 10th. Investors of record on Friday, November 20th will be given a dividend of $1.50 per share on Monday, November 30th. This represents a $6.00 dividend on an annualized basis and a dividend yield of 32.1%. The ex-dividend date is Friday, November 20th. This is a 141.9% increase from abrdn Life Sciences Investors’s previous quarterly dividend of $0.62.
abrdn Life Sciences Investors Stock Performance
NYSE HQL remained flat at $18.67 during trading hours on Wednesday. The company had a trading volume of 27,186 shares, compared to its average volume of 127,409. The stock has a fifty day simple moving average of $18.62 and a 200-day simple moving average of $18.28. abrdn Life Sciences Investors has a 1 year low of $15.66 and a 1 year high of $22.67.
About abrdn Life Sciences Investors
abrdn Life Sciences Investors is a non-diversified, closed-end investment fund focused on companies in the life sciences and health care sectors. Rather than developing or selling products itself, the fund invests in businesses involved in areas such as biotechnology, pharmaceuticals, medical devices and related services. The fund seeks long-term capital appreciation through a portfolio that can include both publicly traded and privately held companies. Its investments may span U.S. and international markets.
See Also
- Five stocks we like better than abrdn Life Sciences Investors
- Alphabet Escalates AI Chip Rivalry With NVIDIA
- Amazon’s Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?
- 3 Stocks Wall Street Likes More Than the Market Does
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
Receive News & Ratings for abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.
